In conclusion, this study investigated an in vitro fatty liver model to demonstrate that PON2 functions by regulating various key features of NAFLD, including mitochondrial homeostasis, lipid metabolism, and inflammation. This evidence concerns the gene PON2 and metabolic dysfunction-associated steatotic liver disease.